Nimbus Therapeutics is a biotechnology company which operates an application of computational chemistry to design treatments for substantial and underserved human diseases. The Company aims to disrupt known drivers of serious diseases, including metabolic disease, cancer, and immune-inflammatory disorders.
|HQ||Cambridge, MA, US||Map|
|Employees (est.) (Sept 2021)||60|
Nimbus Therapeutics total Funding
Nimbus Therapeutics latest funding size
Time since last funding
|3 months ago|
Nimbus Therapeutics investors
|Atlas Venture, SR One, Lilly Ventures, Pfizer Venture Investments, Bill Gates, RA Capital Management, Lightstone Ventures, Richard Friesner, Biotechnology Value Fund, Schrodinger, Surveyor Capital, Logos Capital, Access Biotechnology, Commodore Capital|
Nimbus Therapeutics has 1.17k Twitter Followers. The number of followers has increased 1.1% month over month and increased 7.3% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was Nimbus Therapeutics founded?
Nimbus Therapeutics was founded in 2009.
Who are Nimbus Therapeutics key executives?
Nimbus Therapeutics's key executives are George P. Vlasuk, Scott Edmondson and Erin Cowhig.
How many employees does Nimbus Therapeutics have?
Nimbus Therapeutics has 60 employees.
Who are Nimbus Therapeutics competitors?
Competitors of Nimbus Therapeutics include Codiak Biosciences, Aligos Therapeutics and AstraZeneca.
Where is Nimbus Therapeutics headquarters?
Nimbus Therapeutics headquarters is located at 130 Prospect St #301Cambridge, Cambridge.
Where are Nimbus Therapeutics offices?
Nimbus Therapeutics has an office in Cambridge.
How many offices does Nimbus Therapeutics have?
Nimbus Therapeutics has 1 office.
Receive alerts for 300+ data fields across thousands of companies